In this study, we found that the level of Pim-2 increased in MM patients and was related to energy metabolism, which participated in the cell-cycle progression of myeloma cells, as indicated by mass spectrometry-based untargeted metabolomics analysis. Here, PIM2 is linked to Miyoshi myopathy.